Green Genes Therapeutics

Nothing is just a weed.

We are a company utilizing plants and biotechnology to make strides in health products and recreational food enhancers.

We became incorporated in October 2025 in the United Kingdom and are currently working on production of a plant derivative alternative to synthetic pain relief, the regulation if the sensation can be indicated via genetic biomarkers and monitored for efficacy.

Our Team:

Michael Shipman, CEO;

Michael Shipman is a biomedical researcher and development specialist dedicated to creating sustainable, effective solutions for health and recreation. As CEO of Green Genes, he draws on a multidisciplinary background in plant genetics, phytochemistry, and biomedical technology to advance the company’s mission: delivering non-invasive, environmentally conscious products that benefit both patients and consumers.

Currently completing an M.S. in Biomedical Technology through Syracuse University (Dec. 2025), Michael also serves as an assistant researcher at SUNY ESF, contributing to the American Chestnut Program with a focus on chestnut and beech tree restoration. He holds prior degrees in Economics, Statistics, and Biology, and has led aerobiology research projects mapping airborne pathogens such as Coccidioides spp.

In 2025, Michael collaborated with faculty from Durham University, Dilston Gardens, and Kew Gardens on nociceptive pain and plant pharmacology, deepening his expertise in translational plant science. Originally from Ithaca, NY, he remains committed to environmental stewardship and pragmatic innovation, bridging natural practices with synthetic tools to create scalable, non-evasive benefits.

Andrew Snowball, Chair of the Board;

Andrew Snowball is a Chartered Civil Engineer and experienced industry leader who brings versatility, engineering acumen, and a passion for learning to his role as Board Chair of Green Genes Therapeutics. Alongside his professional career, Andrew serves as Regional Chair for the Institution of Structural Engineers and as a trustee for a local charity, contributing his governance and leadership expertise to organisations that create meaningful impact. His analytical mindset and broad perspective help guide Green Genes through its early development with clarity, structure, and purpose.

Our other areas of research success include:

• Destination aqua chemistry

• Aerobiology including pathogen identification and tracking

• Traditional plant RNA extraction

• Transgenic beverages

• Weather modification - rain induction

Our services include contractual work and partnerships beyond our product listings. Please contact with requests and inquiries.